Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. - Wikidata - awgldk - TriplyDB

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

http://www.wikidata.org/entity/Q37765569

about

Gastroenteropancreatic high-grade neuroendocrine carcinoma The biological hallmarks of ileal carcinoids Topotecan monotherapy in heavily pretreated patients with progressive advanced stage neuroendocrine carcinomas Clinical and pathological features of non-functional neuroendocrine tumors of pancreas: a report from iran Gastric neuroendocrine tumours.Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute Goblet cell carcinoid in a patient with neurofibromatosis type 1: a rare combination.Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances Prospective of ⁶⁸Ga-radiopharmaceutical development.Alternative polyadenylation of tumor suppressor genes in small intestinal neuroendocrine tumors.The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors.Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.A case of insulin and ACTH co-secretion by a neuroendocrine tumour.Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.A descriptive cross-sectional study of pain in patients with neuroendocrine tumors.First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience.Tissue microarray analysis as a screening tool for neuroendocrine carcinoma of the breast.Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors.Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas.Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center.Surgical approach

P2860

Q26998392-3CAA639E-4944-4F83-BE50-93EF935F9EE4 Q28238359-951BECB3-6919-48FB-8D09-0BFD1938C39F Q33417320-E00B5690-AD35-41E4-BE86-79AEBA4DD4CA Q33993022-D00AB0E8-D04C-48BB-A169-EB348730F184 Q34306680-27FB0D24-73C1-4BB5-ABC5-C8A580B58B6A Q34503869-0CBAC565-2999-4A79-B9E0-042CF66E1485 Q36187104-B8D1F68A-9EA2-425A-A2C2-8E47E696DB32 Q36486296-6F071EC4-B2E0-42FD-876E-B5B5A5272638 Q36848763-51300EB2-BD4C-4608-A2BD-3E9598504A37 Q37125550-6BF72054-192A-42D0-9242-53BBD3AFF8FE Q37435222-2376CF5D-B682-475B-9886-EE7587E81952 Q37715730-5394AB2D-5B96-4151-9A4C-274AB11A9E0A Q37869391-0AC4F521-693F-4D3B-B230-DD5123FC2E46 Q37941521-2048AC15-FCEE-4842-B3FC-A0ED56801D7C Q38014495-0192680E-31D7-4017-AFA3-905E45BD3702 Q38499103-C9606156-56A4-4556-85E0-06F8CD8418B2 Q38553657-F0686C0B-8AB4-4EE1-BE5A-F6071EA9A732 Q39084975-0A17DF40-97F6-44DD-96FE-B47081958207 Q39144954-82A0DC84-2364-45A1-9349-A17C5FF0D240 Q44115095-017E8383-22D2-48B2-8F04-9B969CCB2F50 Q46661732-27D35E40-52DC-4749-9712-5B5616E6E906 Q50679640-9DFB883D-EDA0-4A41-9B49-CD0B04ED8409 Q52892914-7EDCDED5-25DD-4D96-AADB-85F37E6D95C5 Q55192213-BBA2FC42-9C99-46E0-AA95-31C15CA1B9D4 Q55360978-CE7BBB2D-B1D9-4566-A445-9BC180B22298 Q55395373-83675E5E-0A08-4F26-A02B-D52011FBDE9A Q57820046-D12B4D21-B54B-4575-AD97-936C5714323F

P2860

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

http://www.wikidata.org/entity/Q37765569

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.

@en

Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.

@nl

type

label

Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.

@en

Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.

@nl

prefLabel

Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.

@en

Nordic Guidelines 2010 for dia ...... reatic neuroendocrine tumours.

@nl

P1433

Q37765569-EA7D750D-6F2C-45F1-92B6-349E92A5AC9A

P1476

Q37765569-2144279B-A0DB-4EC1-8E0C-A1BCEC3CBDF7

P2093

Q37765569-00AE3D9F-8357-4954-B98D-37E5D8AC9585

Q37765569-02CCD1E3-E93D-444E-877A-FBAFACB5A020

Q37765569-27DFFE98-DF4D-4B4F-9AED-D7ABDA68A82A

Q37765569-46DF1DB5-9D35-496D-BF44-A32F1F0309D1

Q37765569-4C8D169C-3A9D-4E81-BEAA-A19CDA24E69C

Q37765569-7A755ACF-6060-4B31-806C-50D0A5488203

Q37765569-9D89E123-8C2F-47CD-B7FE-D0D982B75348

Q37765569-A3316AF5-1814-4434-8FF7-18C5EF5CA541

Q37765569-AA7E1A4B-68EF-4685-BB19-028737A14C5A

Q37765569-D228EA44-6655-4591-A341-E10495C22E71

P2860

Q37765569-0421AF4B-AF2A-430C-9653-E13E2F20F029

Q37765569-0519C038-7FA7-42A3-BD08-63D445C1140C

Q37765569-07F1F6F2-1FE6-4251-896A-686CA37EE958

Q37765569-0A650958-134E-496E-B498-92459DE075BD

Q37765569-0E3408F0-548D-4798-BEF4-6B27F9219FAD

Q37765569-0FF2A244-7D6B-402C-BF75-8560BE1BAFC0

Q37765569-188AE0B5-F71C-4DF0-B962-8BF032665E1F

Q37765569-1BAED40C-65F4-4517-B734-6B934293FF33

Q37765569-29241081-9557-4DB0-9F89-04669CD3B6EE

Q37765569-2DA0EEB8-2DB9-457C-B001-4907E77AA8BF

P304

Q37765569-47B52408-5061-460D-9506-47CF8792B58C

P31

Q37765569-C7035043-D2A8-4E64-A67A-37605386DA27

P356

Q37765569-2766D8FC-2E48-40E1-B9F8-B122E061F140

P433

Q37765569-212BDD7D-FE0F-42AC-A571-1FF6206C889E

P478

Q37765569-F107721A-3E79-40CC-9047-998C88E3391D

P50

Q37765569-370F51DE-3277-42A3-82E1-29FB005D5BAA

P577

Q37765569-44B1802B-DF15-4488-9B95-E93FAAE27819

P698

Q37765569-F30FE7AC-82AD-4ED0-B641-92E356A6022E

P921

Q37765569-c8850f63-6303-4eb1-b029-44d872ec321a

P356

0284186X.2010.492791

P1433

Acta Oncologica

P1476

Nordic Guidelines 2010 for dia ...... creatic neuroendocrine tumours

@en

P2093

Anders Sundin

http://www.w3.org/2001/XMLSchema#string

Birgitte Federspiel

http://www.w3.org/2001/XMLSchema#string

Espen Thiis-Evensen

http://www.w3.org/2001/XMLSchema#string

Eva Tiensuu Janson

http://www.w3.org/2001/XMLSchema#string

Halfdan Sørbye

http://www.w3.org/2001/XMLSchema#string

Henning Grønbaek

http://www.w3.org/2001/XMLSchema#string

Kjell Oberg

http://www.w3.org/2001/XMLSchema#string

Matti J Välimäki

http://www.w3.org/2001/XMLSchema#string

Oystein Mathisen

http://www.w3.org/2001/XMLSchema#string

Per Hellman

http://www.w3.org/2001/XMLSchema#string

P2860

Malignancies of the appendix: beyond case series reports

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

The surgical management of pancreatic neuroendocrine tumors.

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.

Small-cell carcinomas of the gastrointestinal tract: a review.

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract.

P304

740-756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0284186X.2010.492791

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20553100

http://www.w3.org/2001/XMLSchema#string

P921